COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

Hernia Prevention in Stomas

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00907842
Recruitment Status : Completed
First Posted : May 25, 2009
Last Update Posted : April 8, 2013
Information provided by (Responsible Party):
Marc Schreinemacher, Academisch Ziekenhuis Maastricht

Brief Summary:
Knowing that the risk of stoma associated herniation (parastomal or incisional) is 30-50% and the associated morbidity significant, standard placement of a prophylactic mesh upon stoma creation might prevent parastomal (or incisional herniation, after closure) and improve the quality of life of a large group of patients. This study is meant to be a pilot study to see whether the mesh related risks of infection and adhesion morbidity are acceptable if the mesh is placed intraperitoneally.

Condition or disease Intervention/treatment Phase
Incisional Hernia Parastomal Hernia Device: Parietex Parastomal Mesh Not Applicable

Detailed Description:
The idea of a prophylactic mesh has been tested before in a Swedish randomized controlled trial (RCT) with the mesh placed upon end colostomy formation. Results suggest this procedure is the panacea against stoma associated herniations. The investigators still have unanswered questions however, about the size and ideal position of the mesh, possible complications (infection, adhesions) and the benefit in terms of quality of life.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 10 participants
Allocation: N/A
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Prevention
Official Title: Prevention of Parastomal Hernias and Incisional Hernias in Old Stoma Wounds: a Pilot Study
Study Start Date : April 2010
Actual Primary Completion Date : February 2013
Actual Study Completion Date : April 2013

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Hernia

Arm Intervention/treatment
Experimental: mesh placement Device: Parietex Parastomal Mesh
mesh placed intraperitoneally around the stoma

Primary Outcome Measures :
  1. postoperative complications after prophylactic mesh placement around a stoma (i.e., infection of the mesh and adhesions to the mesh) [ Time Frame: one year after placement ]
  2. incisional herniation at the old stoma wound [ Time Frame: two years ]

Secondary Outcome Measures :
  1. stoma complications (stenosis, bulging, prolapse, retraction, skin problems) [ Time Frame: two years after placement ]

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Adult patients with a life expectancy of at least one year
  • Temporary stoma formation
  • Signed informed consent
  • Elective surgery
  • Clean-contaminated abdomen

Exclusion Criteria:

  • American Society of Anaesthesiologists (ASA) score IV or above
  • Incapacitated adult or no signed informed consent
  • Emergency procedure
  • Contaminated or infected abdomen
  • Residual intraperitoneal mesh
  • Already injured part of the abdominal wall where the stoma will be sited
  • Contraindication to laparoscopy
  • Longterm use of corticosteroids and other immunosuppressive agents
  • Current antibiotic therapy
  • One of the following conditions: immune deficiency, chemotherapy, ascites, peritoneal dialysis, pregnancy

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT00907842

Layout table for location information
Maastricht University Medical Centre
Maastricht, Netherlands, 6200 AZ
Sponsors and Collaborators
Marc Schreinemacher
Layout table for investigator information
Study Director: Nicole Bouvy, MD, PhD Maastricht University Medical Centre
Principal Investigator: Marc Schreinemacher, MD Maastricht University Medical Centre
Layout table for additonal information
Responsible Party: Marc Schreinemacher, investigator, Academisch Ziekenhuis Maastricht Identifier: NCT00907842    
Other Study ID Numbers: MEC09-2-052
First Posted: May 25, 2009    Key Record Dates
Last Update Posted: April 8, 2013
Last Verified: April 2013
Keywords provided by Marc Schreinemacher, Academisch Ziekenhuis Maastricht:
Additional relevant MeSH terms:
Layout table for MeSH terms
Incisional Hernia
Pathological Conditions, Anatomical
Postoperative Complications
Pathologic Processes